Evidence map›Paper›PMID 35658519›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor-Positive Early Breast Cancer?

David W Cescon, Kevin Kalinsky, Angela M DeMichele

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

David W CesconDepartment of Medical Oncology, Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-1080-0998
Kevin KalinskyWinship Cancer Institute at Emory University, Atlanta, GA.
Angela M DeMicheleAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-1297-4251
Emory University · USUniversity Health Network · CAUniversity of Pennsylvania · US

Funding

Secondary Prevention through Surveillance and InterventionR01CA208273 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, DEMICHELE, ANGELA · 2017 to 2021
$3.2M
NCI NIH HHS R01 CA208273
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCirculating Tumor DNAErb-b2 Receptor Tyrosine KinasesFemaleHumansPrognosisReceptors, EstrogenCirculating Tumor DNAErb-b2 Receptor Tyrosine KinasesReceptors, Estrogen

Identifiers

PMID35658519
OpenAlexW4281718428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.